Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shenzhen Kangtai Biological Products Co., Ltd.
  6. News
  7. Summary
    300601   CNE100002Q33

SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.

(300601)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021

08/29/2021 | 04:02am EDT

Shenzhen Kangtai Biological Products Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,052.204 million compared to CNY 869.943 million a year ago. Operating income was CNY 387.752 million compared to CNY 304.367 million a year ago. Net income was CNY 336.551 million compared to CNY 259.810 million a year ago. Basic earnings per share from continuing operations was CNY 0.4937 compared to CNY 0.4022 a year ago. Diluted earnings per share from continuing operations was CNY 0.4865 compared to CNY 0.3911 a year ago.


ę S&P Capital IQ 2021
All news about SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
10/21Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Mo..
CI
09/24Shenzhen Kangtai Biological Products Co., Ltd. Announces 2021 Interim Distribution Plan..
CI
09/16Shenzhen Kangtai Biological Products Co., Ltd. Approves Interim Cash Dividend for the F..
CI
09/08Shenzhen Kangtai Biological Products Co., Ltd. Announces Recombinant COVID-19 Vaccine (..
CI
08/30Shenzhen Kangtai Biological Products Co., Ltd. Proposes Cash Dividend for the First Hal..
CI
08/29Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Ye..
CI
08/02Shenzhen Kangtai Biological Products Co., Ltd. Announces Philippine Food and Drug Admin..
CI
07/13SHENZHEN KANGTAI BIOLOGICAL PRODUCTS : Kangtai Biological to Issue $309 Million Renminbi-D..
MT
06/22Phase III Clinical Fieldwork of the Inactivated COVID-19 Vaccine (Vero Cells) Independe..
CI
05/31SHENZHEN KANGTAI BIOLOGICAL PRODUCTS : Kangtai Biological to List 1.3 Million Newly Unlock..
MT
More news
Financials
Sales 2021 3 756 M 588 M 588 M
Net income 2021 1 164 M 182 M 182 M
Net cash 2021 3 514 M 550 M 550 M
P/E ratio 2021 70,2x
Yield 2021 0,20%
Capitalization 81 070 M 12 695 M 12 696 M
EV / Sales 2021 20,6x
EV / Sales 2022 13,8x
Nbr of Employees 2 043
Free-Float 95,8%
Chart SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
Duration : Period :
Shenzhen Kangtai Biological Products Co., Ltd. Technical Analysis Chart | 300601 | CNE100002Q33 | MarketScreener
Technical analysis trends SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 118,00 CNY
Average target price 177,75 CNY
Spread / Average Target 50,6%
EPS Revisions
Managers and Directors
Wei Min Du Chairman & General Manager
Xiang Miao Chief Financial Officer & Board Secretary
Zhi Yun Lu Chairman-Supervisory Board
Xiang Ming Li Independent Director
Dong Guang Ma Independent Director
Sector and Competitors